Aptamer Group PLC
LSE:APTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptamer Group PLC
LSE:APTA
|
UK |
|
D
|
Daewoong Co Ltd
KRX:003090
|
KR |
|
Andon Health Co Ltd
SZSE:002432
|
CN |
|
Q32 Bio Inc
LSE:0T6G
|
US |
|
J
|
Jiangsu Yoke Technology Co Ltd
SZSE:002409
|
CN |
|
S
|
Starhedge SA
WSE:SHG
|
PL |
|
F
|
First Helium Inc
XTSX:HELI
|
CA |
Aptamer Group PLC
Aptamer Group Plc operates as a biotechnology company. The firm provides custom Optimer selection and development services. The firm provides transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. The firm has developed a proprietary platform technology that drives three distinct businesses: Aptamer solutions for custom Optimer development, Aptamer diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer therapeutics for the development of Optimer-based therapeutics. Optimer can act as agonists, antagonists or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.
Aptamer Group Plc operates as a biotechnology company. The firm provides custom Optimer selection and development services. The firm provides transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. The firm has developed a proprietary platform technology that drives three distinct businesses: Aptamer solutions for custom Optimer development, Aptamer diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer therapeutics for the development of Optimer-based therapeutics. Optimer can act as agonists, antagonists or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.
